Paolo Tarantino: So much going on in the ADC field.

Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared the following on Twitter:

“So much going on in the ADC field. Positive press releases, combo trials, multiple new approvals each year, and the first histology-agnostic indication on the horizon.

Yet, much remains to be unveiled on how ADCs work and how to mitigate their toxicities, that too often resemble traditional chemotherapy.

Today I had the honor of discussing these topics with an outstanding panel at the AACR-NCI-EORTC “Triple Meeting”, contributing with a lecture on Optimizing the Toxicites of ADCs, learning from brilliant lectures by Raffaele Colombo & Anthony Tolcher and from the outstanding chairing by Patricia LoRusso & Elisabeth de Vries.”

Source: Paolo Tarantino/LinkedIn